New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Canopy Growth Corporation
CGC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

210M

Drug Manufacturers - Specialty & Generic

Next Earning date - 29 May 2025

210M

Drug Manufacturers - Specialty & Generic

Next Earning date - 29 May 2025

1.67USD

Shape-0.04 ( -2.34%)
sun-fogPre-market 1.16$arrow-right-up0.00 (0.00%)
Market Closed (as of Feb 19, 21:00 EDT)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

37%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

89%

Quote Panel

Shape
Updated March 25, 2025
1W 1.75 % 1M -22.67 % 3M -59.15 % 1Y -83.96 %

Key Metrics

Shape
  • Market Cap

    210.07M


  • Shares Outstanding

    181.09M


  • Share in Float

    180.15M


  • Dividende

    0


  • Earning Date

    29 May 2025


  • Price Target

    1.16


  • Average Volume

    7.91M


  • Beta

    1.733


  • Range

    1.05-14.92


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.canopygrowth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.05x

P/S Ratio

0.30x

P/B Ratio

0.8

Debt/Equity

-169.7%

Net Margin

$-3.5

EPS

How CGC compares to sector?

P/E Ratio

Relative Strength

Shape

CGC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-2.30
vs -4.20

Q2.23

arrow
arrow

N/A

-0.40
vs -7.00

Q3.23

arrow
arrow

N/A

-1.80
vs -2.80

Q4.23

arrow
arrow

N/A

-1.79
vs -3.50

Q1.24

arrow
arrow

N/A

-0.28
vs -2.30

Q2.24

arrow
arrow

N/A

-0.37
vs -0.40

Q3.24

arrow
arrow

N/A

-0.95
vs -1.80

Q4.24

arrow
arrow

N/A

-0.76
vs -1.79

Q1.25

arrow
arrow

N/A

-0.39
vs -0.28

Q2.25

arrow
arrow

N/A

-0.23
vs -0.37

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-22%

87.5M  vs 111.8M

Q2.23

arrow
arrow

-1%

108.7M  vs 110.1M

Q3.23

arrow
arrow

-41%

69.6M  vs 117.9M

Q4.23

arrow
arrow

-22%

78.5M  vs 101.2M

Q1.24

arrow
arrow

-17%

72.8M  vs 87.5M

Q2.24

arrow
arrow

-39%

66.2M  vs 108.7M

Q3.24

arrow
arrow

-9%

63M  vs 69.6M

Q4.24

arrow
arrow

+10%

86.2M  vs 78.5M

Q1.25

arrow
arrow

-1%

71.8M  vs 72.8M

Q2.25

arrow
arrow

+9%

72.1M  vs 66.2M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-85%

-0.85
vs -0.19

Q2.23

arrow
arrow

-5%

-0.05
vs -0.85

Q3.23

arrow
arrow

-41%

-0.41
vs -0.05

Q4.23

arrow
arrow

-40%

-0.40
vs -0.41

Q1.24

arrow
arrow

-18%

-0.18
vs -0.40

Q2.24

arrow
arrow

-24%

-0.24
vs -0.18

Q3.24

arrow
arrow

-25%

-0.25
vs -0.24

Q4.24

arrow
arrow

-21%

-0.21
vs -0.25

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

345

345
vs 368

-6%

Q2.23

arrow
arrow

323

323
vs 345

-6%

Q3.23

arrow
arrow

329

329
vs 323

2%

Q4.23

arrow
arrow

228

228
vs 329

-31%

Q1.24

arrow
arrow

246

246
vs 228

8%

Q2.24

arrow
arrow

251

251
vs 246

2%

Q3.24

arrow
arrow

243

243
vs 251

-3%

Q4.24

arrow
arrow

245

245
vs 243

1%

Earnings Growth

Latest News